Form 8-K - Current report:
SEC Accession No. 0001493152-23-038052
Filing Date
2023-10-24
Accepted
2023-10-24 09:00:16
Documents
15
Period of Report
2023-10-05
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37922
2 ex3-1.htm EX-3.1 103462
3 ex3-2.htm EX-3.2 67510
4 ex99-1.htm EX-99.1 15114
  Complete submission text file 0001493152-23-038052.txt   422952

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT btax-20231005.xsd EX-101.SCH 3024
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT btax-20231005_lab.xml EX-101.LAB 34916
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT btax-20231005_pre.xml EX-101.PRE 22795
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3291
Mailing Address 2431 ALOMA AVE #124 WINTER PARK FL 32792
Business Address 2431 ALOMA AVE #124 WINTER PARK FL 32792 (888) 613-8802
Biostax Corp. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54933 | Film No.: 231341276
SIC: 2834 Pharmaceutical Preparations